# A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

> **NCT03014674** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 246 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** Lyophilized mepolizumab
- **BIOLOGICAL:** Liquid mepolizumab
- **DEVICE:** Prefilled autoinjector
- **DEVICE:** Prefilled Safety Syringe

## Key facts

- **NCT ID:** NCT03014674
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-06
- **Primary completion:** 2017-08-11
- **Final completion:** 2017-08-11
- **Target enrollment:** 246 (ACTUAL)
- **Last updated:** 2019-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03014674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03014674, "A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03014674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*